Copy
Welcome to our December 2020 Newsletter!
Watch for a new mini edition each month...
View this email in your browser

In This Issue

  • NSIV in the news
  • New Member, Keralia Tech
  • Keeping up with NSIV
  • What's going on
  • News from Mass Bio
  • News from MLSC

NSIV Website

Find all these stories and more on our website! Stay informed at NSIV.org.

Keep Up With Us

LinkedIn LinkedIn
Twitter Twitter
Facebook Facebook
YouTube YouTube
NSIV in the News
NSIV loans Anna Jaques Hospital in Newburyport its ultracold freezer for COVID-19 vaccine storage.  NSIV CEO Chris Ilsley first offered the use of the freezer to Beverly Hospital. But when hospital administrators there informed them they did not need one, they suggested contacting Anna Jaques.  “We just hope our effort will help the hospital get this important vaccine out at this crucial time,” Ilsley said, adding that his company wanted to aid front-line workers as much as possible.

Go NSIV!

See details in full Salem Evening News article published 12/24/20.
                                                
                                                                                    Courtesy photo Beverly-based North Shore InnoVentures is loaning Anna Jaques Hospital an ultracold freezer so it can store vials of the Pfizer-BioNtech COVID-19 vaccine.  Pictured, from the left , Mary Williamson, executive director of  Anna Jaques Community Health Foundation; Yinka Ojutalayo, director of pharmacy; Bob Barton North Shore InnoVentures board member; and hospital president Mark Goldstein.
           Keralia Tech is NSIV’s newest member. A French company, headquartered in Paris, they are represented at NSIV by Arthur De Gery, in charge of US operations. Keralia Tech was born from a team of technology experts and scientists, who combined their forces to change the approach to discovery research IT. Nowadays, most scientists struggle with bad IT systems and lose up to 6 hours per week on experiment planning. That is one day per week lost for science. To tackle this issue, Keralia built an innovative service portal where lab users can find all accessible resources, including instruments, consumables, protocols, training, research computing services, and more! They are currently working to employ their software platform at NSIV to help us maximize the use of our lab equipment. Read more about Keralia here.
 
Keeping up with NSIV
            CrowdComfort has secured $2 million from private investors, private organizations including Saint-Gobain, and investors through an equity crowdfunding platform, SeedInvest.  The firm has raised $7.5 million to date and the recent funding will be used to support items like their launch of the new IOS user interface, which is now available in the App Store.  The new interface offers several enhancements that will ensure better data capture and improve the user experience for employees facilities and teams.

CrowdComfort’s mobile facilities management app and analytics platform enable employees and management to collaborate to reduce facilities costs and create great work environments, producing happier and more productive employees.

Genomic Expression is launching a saliva-based COVID19 testing protocol, (licensed from Yale).  Saliva testing has some significant benefits. The test kit will be available to companies only with a limited supply available for December. 

You can establish your account today with this attached link.     
               

Each week or so, we've been introducing one of the people who work for a NSIV member company. Most recently, it was Michael Kerr of New England Hydropower.   
Keep watching for more NSIV member profiles on LinkedIn, Twitter, and Facebook 


What's Going On?

After more than 13 years, Robert K. Coughlin announced that he will be stepping down as President & CEO of MassBio in early 2021. Under Coughlin's tutelage, the council has grown to over 1,400 members from across the life sciences. The job and MassBio’s mission were always a personal one to Coughlin. While in office, he has been able to see firsthand the power of the Massachusetts cluster. His son was born 18 years ago with cystic fibrosis. Because of decades of work and billions of dollars invested by a Massachusetts company, a drug was recently approved that has made his son healthier. 

As MassBio looks forward, Chief Operating Officer Kendalle Burlin O’Connell, is being promoted to President and COO, and Zach Stanley, Vice President of Public Affairs, is being promoted to Executive Vice President. Together, they along with Kristine Kelly, VP of Administration & Finance, will lead the organization in 2021 as the nationwide search for a new CEO takes place under the guidance of a Board led search committee and an executive search firm.

 
The MLSC is excited to announce the latest round of its Tax Incentive program to create long-term jobs, build a robust workforce, and propel the development of new therapies, devices, and scientific advancements that are improving patient health and well-being.
 
The Center will accept applications starting, December 7th, with an application deadline on Feb. 5, 2021. To learn more about the application process and the latest round, MLSC staff invite you to engage virtually at one of four upcoming webinars.
 
Learn more and register for a webinar today.

Copyright © 2019 North Shore InnoVentures, All rights reserved. 
You are receiving our newsletter because you have indicated that you wished to receive updates on NSIV events and news. Please let us know how we can best keep you up to date! 
Our mailing address is: 
North Shore InnoVentures
100 Cummings Center
Suite 451C
Beverly, MA 01915
Add us to your address book
Email Marketing Powered by MailChimp
 unsubscribe from this list | update subscription preferences 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
North Shore InnoVentures · 100 Cummings Center · Suite 451C · Beverly, MA 01915 · USA

Email Marketing Powered by Mailchimp